Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Current data on gabapentin].

¹Servicio de Neuropediatría, Hospital Universitario Marqués de Valdecilla, Santander, España. med003087@nacom.es

Revista De Neurologia

|July 25, 2000

Summary

Gabapentin (GBP) is an effective antiepileptic drug for all ages with partial seizures. Higher doses are recommended due to its excellent tolerance and favorable pharmacokinetics for improved seizure control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Antiepileptic drugs].

Revista de neurologia·2018

Same author

[Rufinamide. A review of its pharmacokinetic and pharmacodynamic properties].

Revista de neurologia·2008

Same author

[Rational combination therapy in epilepsy. III. Possible associations between antiepileptic drugs].

Revista de neurologia·2007

Same author

[Rational combination therapy in epilepsy. II. Clinical and pharmacological aspects].

Revista de neurologia·2007

Same author

[Rational combination therapy in epilepsy. I. Concepts and foundations].

Revista de neurologia·2007

Same author

[Cognitive repercussion of early-onset epilepsies].

Revista de neurologia·2007

Area of Science:

Pharmacology
Neurology
Clinical Pharmacy

Background:

Gabapentin (GBP) exhibits a multifaceted mechanism of action.
Its utility extends beyond epilepsy to neuropathic pain, psychiatric disorders, movement disorders, and migraines.

Purpose of the Study:

To review current data on gabapentin (GBP).
Focus on mechanism of action, pharmacokinetics, clinical efficacy, tolerance, and administration.
Evaluate GBP's role in epilepsy and other conditions.

Main Methods:

Literature review of existing data on gabapentin.
Analysis of pharmacokinetic properties and drug interactions.
Assessment of clinical efficacy in monotherapy and polytherapy for partial seizures.

Main Results:

Gabapentin demonstrates multiple mechanisms of action, supporting its use in diverse conditions.
Pharmacokinetic profile is favorable, with minimal drug interactions.
Significant evidence supports GBP's efficacy in adults and children with partial seizures, with rare adverse effects.
Dosing can be rapidly titrated.

Conclusions:

Gabapentin is effective for partial seizures across all age groups.
Excellent tolerance and dose-dependent kinetics support higher recommended dosages.
Suggested dosages range from 900-2,400 mg/day for new diagnoses, 1,800-3,600 mg/day as a second-line option, and 2,400-4,800 mg/day when other treatments fail.

Related Experiment Videos